Dr. Krahn, Dr. Green and Dr. Hansom

Virtual

The pathologist’s role in the evaluation of sudden cardiac death - Dr. Kristopher Cunningham Improving Families’ Experiences When a Young Relative Dies of Sudden Cardiac Death - Dr. Katherine Allan A family’s experience Q+A

Round table discussion - "Initiating Change - Establishing the next steps in developing a national framework for the referral of SCD families": (Panel discussion and open mic) Dr. Kristopher Cunningham, Dr. Katherine Allan, chair Dr. Martin Green / Dr. Simon Hansom. Learning objectives; 1. Explain the vital role of appropriate referral of families at risk of IA syndromes 2. Define the regional and national challenges / barriers to a national framework for the referral of SCD families 3. Develop a consensus on next steps towards initiating change

Virtual

11:00: SAECG has no role in the diagnosis and follow up of arrhythmogenic cardiomyopathy Dr. Jason Roberts (pro) and Dr. Julia Cadrin-Tourigny (con) Learning objectives: 1. Provide an overview of the pathophysiological basis of the SAECG as it relates to ACM 2. Outline the current role of the SAECG in the diagnosis of ACM 3. Outline the evidence for and against the ongoing clinical use of the SAECG in the diagnosis of ACM 11:30: Scrap the phenotype - Whole exome sequencing should be performed in all cardiac arrest survivors Dr. Rafik Tadros (pro) and Dr. Andrew Krahn (con) Learning objectives: 1. Provide an overview of the role of WES in the assessment of cardiac arrest survivors. 2. Discuss the importance of phenotype assessment in cardiac arrest survivors.

Virtual

What would I tell my younger self - navigating adolescence with an inherited arrhythmia Dr. Susan Etheridge Learning objectives: 1. Outline the inherited arrhythmias as they are expressed in adolescence. 2. Explain some of the unique issues that physicians face when caring for an adolescent with an inherited arrhythmia. 3. Outline some strategies for optimizing care of the adolescent with an inherited arrhythmia condition

Virtual

1:30 pm: Imaging in inherited cardiomyopathy: Dr. Habib Khan Learning objectives: Describe the superiority of certain imaging modalities over others in the assessment of rare cardiomyopathies Define the role of cardiac MRI in the diagnosis of LV non compaction 1:45 pm: Idiopathic VF: Dr. Deepti Ranganathan Learning objectives: 1. Describe the challenges associated with managing Idiopathic VF 2. Highlight the high risk of recurrence 3. Outline the role of PVCs as triggers for recurrent ICD shocks and the importance of managing appropriately. 2:00 pm: An unusual case of sudden cardiac death in a child: Dr. Sharmila Udupa Learning objectives: 1. Determine the risk of sudden cardiac death in children without documented arrhythmia 2. Outline the ethical principles in primary prevention strategies in children

Virtual

2:15 pm: How do we manage consumer driven genetic testing: Ms. Julie Rutberg Learning objectives: 1. Outline the current availability of cardiac genetic testing for consumers. 2. Recall the challenges of genetic testing in the setting of preventative health 3. Identify the need for outcomes data after genetic testing in healthy consumers 2:30 pm: Not all patients with LQT syndrome require therapy: Dr. Ciorsti MacIntyre Learning objectives: 1. Recall how genotype specific variables influence risk in LQTS 2. Describe the treatment options to reduce arrhythmia risk in LQT patients 2:45 pm: Establishing LCSD expertise in Canada + Round table discussion: Dr. Joe Atallah & Dr. Bryan Dicken 1. Describe the role of LCSD in the treatment of inherited arrhythmia syndromes 2. Recall the surgical approach to LCSD 3. Outline the regional and national challenges to establishing expertise in LSCD in Canada

Virtual

3:45 pm: The promise of gene therapy: Dr. Jason Roberts Learning objectives: 1. Outline the Contemporary Methods to Modulate Gene Expression and Function: RNA Knockdown, Gene Therapy and Gene Editing 2. Recall the Ongoing and Upcoming Clinical Trials for these Modalities in Cardiovascular Medicine 3. Identify the Ongoing Challenges Still to be Overcome 4:00 pm: Targeted therapy in HCM: Dr. Thomas Roston Learning objectives: 1. Recall the etiologic mechanisms behind HCM 2. Describe the evidence that supports myosin inhibitors as a novel class of drug therapy for HCM 3. Discuss the promise of gene therapy for HCM 4:15 pm: Stem Cells - Where are we now, the past, present and future: Dr. Darryl Davis Learning objectives: 1. Recall the potential of stem cell-based therapies in the treatment of inherited arrhythmias. 2. Evaluate the current state of stem cell-based therapies for inherited arrhythmias and future directions. 4:30 pm: Arrhythmogenic Mitral Valve Prolapse: Dr. Wael Alqarawi Learning objectives: 1. Recollect the definition of arrhythmic mitral valve prolapse (AMVP) 2. Describe the risk markers for arrhythmic outcomes in AMVP 3. Outline the ICD indications for AMVP 4:45 pm: Assessing Risk in TMEM43 associated Arrhythmogenic Cardiomyopathy - Dr. Steve Duffett Learning objectives: 1. Recall the importance of penetrance in risk associated with specific variants. 2. Outline challenges present in assessing risk in ARVC due to TMEM43.

Virtual

Executive: Ms. Brianna Davies Governance: Dr. Colette Seifer Research: Dr. Jason Roberts Clinical Care: Drs. Colette Seifer & Susan Christian HiRO Karen Gibbs Bursary Award: Dr. Andrew Krahn ​

Location TBD